verona pharma plc
(VRP:London Stock Exchange)
Clive P. Page BSc,Ph.D.
Former Non-Executive Chairman, President and Chairman of Nomination & Corporate Governance Committee, Verona Pharma plc
|Age||Total Calculated Compensation||This person is connected to 15 board members in 3 different organizations across 7 different industries.|
See Board Relationships
Prof. Clive P. Page, B Sc, PhD, has been a Professor and Head of the Sackler Institute of Pulmonary Pharmacology at the School of Biomedical Sciences, King's College, University of London since 1994 and a Consultant to the pharmaceutical industry. Prof. Page served as the President and Senior Scientific Officer of Verona Pharma Plc (formerly known as Rhinopharma Limited). He is recognized as a World Expert in asthma and other inflammatory diseases and has published widely ...
3 More London RiversidePhone: 44 20 3283 4200
London, Greater London SE1 2RE
Board Members Memberships*
Former Non Executive Chairman
Former Non-Executive Chairman, President and Chairman of Nomination & Corporate Governance Committee
King's College London
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Clive A. Meanwell M.D., Ph.D.||Chairman and Chief Executive Officer|
The Medicines Company
|John C. Lechleiter Ph.D.||Chairman, Chief Executive Officer and President|
Eli Lilly and Company
|Kenneth C. Frazier||Chairman, Chief Executive Officer and President|
Merck & Co. Inc.
|Albert David Friesen Ph.D.||Founder, Chairman and Chief Executive Officer|
|C$105.0K||Compensation as of Fiscal Year 2014.|